education, training, board certifications
- M.D., Stanford University
- Residency in Internal Medicine, University of California, San Francisco
- Fellowship in Hematology/Oncology, Stanford University
- Internal Medicine, American Board of Internal Medicine
- Hematology, American Board of Internal Medicine
- Oncology, American Board of Internal Medicine
clinical expertise
- Acute lymphoblastic leukemia
- Acute myeloid leukemia
- Leukemia
- Myelodysplastic syndrome
- Myelomonocytic leukemia
- Myeloproliferative neoplasms
affiliations
University of Washington
Fred Hutchinson Cancer Center - Faculty & Labs
Fred Hutchinson Cancer Center - Provider
publications
clinical and/or research interests
Dr. Mary-Elizabeth Percival develops early-phase clinical trials for patients with acute myelogenous leukemia (AML), specifically testing new drugs and new combinations of drugs. Additionally, she performs epidemiological research, using data from patients with AML treated at UW and beyond.
